425 filed Jul 20, 2026 at 09:19 ET
Tempus AI (TEM) announced a definitive agreement to acquire Personalis (PSNL) for $16.25 per share in a stock transaction valued at $1.5 billion enterprise value, representing a 6% premium to the prior close and a 28% premium to the 30-day VWAP. The deal combines Personalis' MRD technology with Tempus' AI platform and commercial infrastructure, with closing expected in late 2026 or early 2027. Personalis also reported preliminary Q2 revenue of $22.4 million and 10,384 clinical tests, a 33% sequential volume increase.